Semaglutide’s heart benefits may extend beyond weight loss
Semaglutide is known to reduce the risk of serious heart disease. However, a new study published in the European Heart Journal today (Thursday) suggests that this effect cannot not be entirely explained by patients losing weight on the drug.
Read original article on The Medical News →Related news
-
Chronic postsurgical pain affects women long after cesarean delivery
-
Blood proteins may help monitor Alzheimer’s treatment response
-
Intuitive eating may be linked to more than a healthier relationship with food
-
Neuromedin U drives immune suppression in aggressive prostate cancer
-
Scientists gave worms magnetic bacteria. They lived 43% longer
-
Why are more younger adults in the Eastern Mediterranean facing colorectal cancer?
-
USP15 enzyme emerges as potential target for ovarian cancer treatment
-
Uterus transplantation shows improving outcomes and successful births nationwide